HP
HealthInvest Partners Portfolio holdings
AUM
$234M
1-Year Return
10.88%
This Quarter Return
+15.31%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$51.8M
AUM Growth
+$4.44M
(+9.4%)
Cap. Flow
-$393K
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
97.02%
Holding
55
New
45
Increased
2
Reduced
5
Closed
2
Top Buys
| 1 |
GSK
GSK
|
+$5.27M |
| 2 |
CVS Health
CVS
|
+$4.85M |
| 3 |
Cardinal Health
CAH
|
+$2.31M |
| 4 |
Utah Medical Products
UTMD
|
+$804K |
| 5 |
UnitedHealth
UNH
|
+$201K |
Top Sells
| 1 |
McKesson
MCK
|
+$4.42M |
| 2 |
Gilead Sciences
GILD
|
+$3.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$2.37M |
| 4 |
OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
|
+$2.26M |
| 5 |
Zevra Therapeutics
ZVRA
|
+$1.93M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Merus
MRUS
$5.26B
| $4.42K | 0.01% |
+286
| New | +$4.42K |
|
52
Arcellx
ACLX
$4.23B
| $4.4K | 0.01% |
+142
| New | +$4.4K |
|
53
Denali Therapeutics
DNLI
$2.07B
| $4.39K | 0.01% |
+158
| New | +$4.39K |
|
|
54
McKesson
MCK
$88.5B
| – | – |
-13,000
| Closed | -$4.42M |
|
|
OPNT
55
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| – | – |
-210,000
| Closed | -$2.26M |
|